Safety and Effectiveness of a Multifocal Intraocular Lens (IOL)

Inclusion Criteria: * Visual potential of 20/30 or better in each study eye * Preoperative BCDVA worse than Snellen 20/40 or worse than 20/30 in the presence of glare (as measured using a Snellen chart with BAT at medium) * Naturally dilated pupil size (in dim light) \> 4.0 mm (with no dilation medications) for each study eye * Preoperative corneal astigmatism of 1.0 D or less Exclusion Criteria: * Use of systemic or ocular medications that may affect vision (the use of any miotic agent is specifically contraindicated) * Acute or chronic disease or illness that would increase the operative risk or confound the study outcome(s),(e.g., diabetes mellitus, immunocompromised, connective tissue disease, etc.) * Uncontrolled systemic or ocular disease * History of ocular trauma or prior ocular surgery or subjects expected to require retinal laser treatment or other surgical intervention * Presence of ocular pathology other than cataract such as: * Amblyopia or strabismus * Corneal abnormalities * Pupil abnormalities * Capsule or zonule abnormalities * Intraocular inflammation * Known pathology that may affect visual acuity and/or are predicted to cause future acuity losses to a level of 20/30 or worse (e.g. macular degeneration) * Requiring an intraocular lens outside the study diopter range * Contact lens usage prior to study procedure (time interval dependent upon contact lens type)